2024년에 12억 달러로 추정되는 진단용 특수 효소 세계 시장은 분석 기간인 2024-2030년에 CAGR 6.2%로 성장하여 2030년에는 17억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 폴리메라아제 및 뉴클레아제는 CAGR 7.0%를 기록하며 분석 기간 종료시에는 7억 2,620만 달러에 달할 것으로 예측됩니다. 프로테아제 분야의 성장률은 분석 기간 동안 CAGR 6.5%로 추정됩니다.
미국 시장은 3억 2,890만 달러로 추정, 중국은 CAGR 5.7%로 성장 예측
미국의 진단용 특수 효소 시장은 2024년에 3억 2,890만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 5.7%로 2030년까지 2억 6,670만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 5.5%와 5.2%로 예측됩니다. 유럽에서는 독일이 CAGR 4.6%로 성장할 것으로 예측됩니다.
세계의 진단용 특수 효소 시장 - 주요 동향과 촉진요인 정리
진단용 특수 효소가 현대 진단에 필수적인 이유는 무엇일까?
진단용 특수 효소는 진단 분석법 개발에 있어 매우 중요한 구성요소이며, 다양한 질병 및 상태의 검출에 있어 기본적인 역할을 합니다. 이들 효소는 임상 화학, 분자진단, 면역 측정에서 당뇨병, 심혈관질환, 감염과 같은 바이오마커를 식별하는 데 도움이 되는 특정 반응을 촉매하는 데 사용됩니다. 특수 효소의 정확성과 효율성은 진단에 필수적이며, 의료 전문가가 정확하고 시기적절한 결과를 제공할 수 있도록 돕습니다. 현장진단(POCT) 및 가정용 진단 키트에 대한 수요가 증가함에 따라 특수 효소의 사용이 확대되고 있으며, 신속하고 정확한 검사 솔루션에 대한 수요 증가에 대응하는 데 필수적인 생화학적 도구를 제공하고 있습니다.
기술 발전은 진단용 효소 시장에 어떤 영향을 미치고 있는가?
진단용 특수 효소 시장은 효소 공학 및 생산 방법의 기술적 진보로 인해 크게 성장하고 있습니다. 유전공학 및 재조합 DNA 기술은 이러한 효소의 안정성, 특이성 및 활성을 향상시켜 진단 응용 분야에서 더욱 효과적으로 사용할 수 있게 해줍니다. 또한, 마이크로유체공학 및 랩온어칩 기술의 혁신으로 효소가 소형 진단 기기에 통합되어 임상 및 현장 진료 환경에서 보다 빠르고 정확한 검사를 가능하게 하고 있습니다. 효소 결합 면역 흡착 분석법(ELISA) 및 기타 효소 기반 진단 플랫폼의 개발도 발전하여 여러 바이오마커를 동시에 검출할 수 있는 고처리량 검사 및 멀티플렉스 검사가 가능해졌습니다. 이러한 발전은 진단용 특수 효소의 효율성과 범용성을 향상시켜 최신 진단의 적용 범위를 넓히고 있습니다.
시장 수요와 헬스케어 트렌드가 효소 시장을 어떻게 형성하고 있는가?
조기 진단 및 예방 의료에 대한 수요 증가는 진단용 특수 효소 시장에 큰 영향을 미치고 있습니다. 전 세계 의료 시스템이 예방 의료로 전환됨에 따라 질병을 조기에 발견할 수 있는 진단 도구의 개발이 중요해지고 있습니다. 효소는 이러한 도구 개발, 특히 대사 이상, 감염 및 유전적 질환의 검출에 중요한 역할을 하고 있습니다. 당뇨병 및 심혈관질환과 같은 만성질환의 유병률이 증가함에 따라 신속하고 신뢰할 수 있는 결과를 제공하는 효소 기반 진단 검사에 대한 수요가 증가하고 있습니다. 또한, 포도당 모니터, 신속 항원 검사 등 자가 진단 및 자가 모니터링 기기의 성장으로 진단용 특수 효소의 사용은 전통적인 실험실 환경 외의 영역으로 확대되고 있습니다. 또한, 맞춤형 의료 및 맞춤형 치료의 트렌드도 시장에 영향을 미치고 있습니다. 이러한 효소는 맞춤형 의료를 지원하는 정확하고 표적화된 진단 분석을 촉진할 수 있기 때문입니다.
진단용 특수 효소 시장의 성장을 촉진하는 요인은 무엇인가?
진단용 특수 효소 시장의 성장은 효소 공학의 기술 발전, 만성질환 및 감염성 질환의 유병률 증가, 신속한 진단 테스트 솔루션에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 예방적이고 개인화된 의료 서비스로의 전환은 신속하고 정확하며 휴대 가능한 솔루션을 제공하는 효소 기반 진단 도구의 개발을 촉진하고 있습니다. 특히 COVID-19 팬데믹으로 인해 POCT(Point-of-Care Test, 현장진단(POCT) 및 재택진단 키트가 확대되면서 이러한 용도에 맞는 특수 효소에 대한 수요가 더욱 증가하고 있습니다. 또한, 암, 당뇨병, 심혈관질환과 같은 질병에 대한 고감도 및 특이적인 진단 분석법 개발에 대한 관심이 높아지면서 효소 기술에 대한 투자가 촉진되고 있습니다. 정부 이니셔티브와 헬스케어 개혁에 힘입어 신흥 시장에서의 접근성 높은 헬스케어 솔루션의 보급도 진단용 특수 효소 시장의 세계 확대에 기여하고 있습니다.
부문
제품(폴리메라아제·뉴클레아제, 프로테아제, 탄수화물, 옥시다아제, 기타 제품), 용도(임상화학, 분자진단, 면역측정, 기타 용도)
조사 대상 기업 사례
Advanced Enzymes Technologies Ltd.
Affymetrix, Inc.
Amano Enzymes Inc.
American Laboratories, Inc.
Amicogen, Inc.
BASF
BBI Solutions
Biocatalysts Ltd.
Codexis, Inc.
Dyadic International
F. Hoffmann-La Roche Ltd.
Life technologies
Micogen, Inc.
Nagase & Co. Ltd.
Novozymes A/S
Roche Holding Ag
Thermo Fisher Scientific, Inc.
AI 통합
우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범에 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Diagnostic Specialty Enzymes Market to Reach US$1.7 Billion by 2030
The global market for Diagnostic Specialty Enzymes estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polymerases & Nucleases, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$726.2 Million by the end of the analysis period. Growth in the Proteases segment is estimated at 6.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$328.9 Million While China is Forecast to Grow at 5.7% CAGR
The Diagnostic Specialty Enzymes market in the U.S. is estimated at US$328.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$266.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.
Why Are Diagnostic Specialty Enzymes Essential in Modern Diagnostics?
Diagnostic specialty enzymes are crucial components in the development of diagnostic assays, playing a fundamental role in the detection of various diseases and conditions. These enzymes are used in clinical chemistry, molecular diagnostics, and immunoassays to catalyze specific reactions that help identify biomarkers for diseases such as diabetes, cardiovascular conditions, and infectious diseases. The precision and efficiency of specialty enzymes make them indispensable in diagnostics, enabling healthcare professionals to deliver accurate and timely results. As the demand for point-of-care testing (POCT) and home diagnostic kits grows, the use of specialty enzymes is expanding, providing the essential biochemical tools needed to meet the rising need for quick and accurate testing solutions.
How Are Technological Advancements Influencing the Diagnostic Enzymes Market?
The diagnostic specialty enzymes market is witnessing significant growth due to technological advancements in enzyme engineering and production methods. Genetic engineering and recombinant DNA technology are enhancing the stability, specificity, and activity of these enzymes, making them more effective in diagnostic applications. Additionally, innovations in microfluidics and lab-on-a-chip technologies are integrating enzymes into compact diagnostic devices, enabling faster and more accurate testing in clinical and point-of-care settings. The development of enzyme-linked immunosorbent assays (ELISAs) and other enzyme-based diagnostic platforms is also evolving, allowing for high-throughput and multiplex testing that can simultaneously detect multiple biomarkers. These advancements are increasing the efficiency and versatility of diagnostic specialty enzymes, broadening their application in modern diagnostics.
How Are Market Demands and Healthcare Trends Shaping the Enzymes Market?
The rising demand for early diagnosis and preventive healthcare is significantly influencing the diagnostic specialty enzymes market. As healthcare systems worldwide shift towards preventive care, there is a growing emphasis on the development of diagnostic tools that can detect diseases at early stages. Enzymes play a critical role in the creation of these tools, particularly in the detection of metabolic disorders, infections, and genetic conditions. The increasing incidence of chronic diseases like diabetes and cardiovascular conditions is driving demand for enzyme-based diagnostic tests that offer quick and reliable results. Additionally, the growth of home-based testing and self-monitoring devices, such as glucose monitors and rapid antigen tests, is expanding the use of diagnostic specialty enzymes beyond traditional laboratory settings. The trend towards personalized medicine and tailored treatments is also influencing the market, as these enzymes facilitate precise and targeted diagnostic assays that support individualized healthcare.
What Factors Are Driving Growth in the Diagnostic Specialty Enzymes Market?
The growth in the diagnostic specialty enzymes market is driven by several factors, including technological advancements in enzyme engineering, the rising prevalence of chronic and infectious diseases, and the increasing demand for rapid diagnostic testing solutions. The shift towards preventive and personalized healthcare is encouraging the development of enzyme-based diagnostic tools that provide quick, accurate, and portable solutions. The expansion of point-of-care testing (POCT) and home-based diagnostic kits, particularly in the wake of the COVID-19 pandemic, is further driving demand for specialty enzymes that are tailored for these applications. Additionally, the growing emphasis on developing sensitive and specific diagnostic assays for diseases like cancer, diabetes, and cardiovascular conditions is propelling investment in enzyme technology. The push for accessible healthcare solutions in emerging markets, supported by government initiatives and healthcare reforms, is also contributing to the expansion of the diagnostic specialty enzymes market globally.
SCOPE OF STUDY:
The report analyzes the Diagnostic Specialty Enzymes market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases, Other Products); Application (Clinical Chemistry, Molecular Diagnostics, Immunoassays, Other Applications)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 14 Featured) -
Advanced Enzymes Technologies Ltd.
Affymetrix, Inc.
Amano Enzymes Inc.
American Laboratories, Inc.
Amicogen, Inc.
BASF
BBI Solutions
Biocatalysts Ltd.
Codexis, Inc.
Dyadic International
F. Hoffmann-La Roche Ltd.
Life technologies
Micogen, Inc.
Nagase & Co. Ltd.
Novozymes A/S
Roche Holding Ag
Thermo Fisher Scientific, Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Tariff Impact on Global Supply Chain Patterns
Diagnostic Specialty Enzymes - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Early Diagnosis and Preventive Healthcare
Growth in Point-of-Care and Rapid Testing Solutions Boosting Enzyme Use
Increasing Adoption of Specialty Enzymes in Molecular Diagnostics
Technological Advancements in Enzyme Engineering for Enhanced Sensitivity
Surge in Use of Enzymes for Cancer and Genetic Disorder Detection
Development of Multiplex Diagnostic Assays Incorporating Specialty Enzymes
Growth in Home-Based and Self-Monitoring Diagnostic Kits
Expansion of Diagnostic Services in Emerging Markets Supporting Enzyme Demand
Rising Focus on Personalized Medicine and Targeted Diagnostics
Increasing Collaboration Between Diagnostic Companies and Enzyme Providers
Growth in Use of Enzymes for Monitoring Infectious Diseases
Advancements in Microfluidics and Lab-on-a-Chip Technologies Using Enzymes
Rising Investment in R&D for Enzyme Optimization and Stability
Expansion of Enzyme Applications in Veterinary Diagnostics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Diagnostic Specialty Enzymes Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Diagnostic Specialty Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Diagnostic Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Polymerases & Nucleases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Polymerases & Nucleases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Proteases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Proteases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Proteases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Oxidases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Oxidases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Oxidases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: USA Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: USA 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: USA Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: USA 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: Canada 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: Canada 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
JAPAN
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 44: Japan Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: Japan 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Japan 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
CHINA
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: China Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: China 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 53: China Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: China Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: China 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
EUROPE
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 56: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Diagnostic Specialty Enzymes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: Europe 15-Year Perspective for Diagnostic Specialty Enzymes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Europe 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Europe 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
FRANCE
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 65: France Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: France Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: France 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 68: France Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: France Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: France 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
GERMANY
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 71: Germany Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Germany 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 74: Germany Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: Germany 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
ITALY
TABLE 77: Italy Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: Italy 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 80: Italy Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Italy 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
UNITED KINGDOM
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 83: UK Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: UK Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: UK 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 86: UK Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: UK Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: UK 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Rest of Europe 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Diagnostic Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Asia-Pacific 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 101: Rest of World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Rest of World Historic Review for Diagnostic Specialty Enzymes by Product - Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Rest of World 15-Year Perspective for Diagnostic Specialty Enzymes by Product - Percentage Breakdown of Value Sales for Polymerases & Nucleases, Proteases, Carbohydrates, Oxidases and Other Products for the Years 2015, 2025 & 2030
TABLE 104: Rest of World Recent Past, Current & Future Analysis for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Rest of World Historic Review for Diagnostic Specialty Enzymes by Application - Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: Rest of World 15-Year Perspective for Diagnostic Specialty Enzymes by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Molecular Diagnostics, Immunoassays and Other Applications for the Years 2015, 2025 & 2030
